通过植入前遗传学检测在人类胚胎中常规检测近亲血缘关系
本研究利用29例临床植入前遗传学检测(PGT)病例(5例确诊近亲血缘关系为阳性对照,24例随机选取的非近亲血缘关系为阴性对照)建立基于单核苷酸多态性微阵列的PGT平台常规检测胚胎近亲血缘关系的阈值。将阈值应用于6380例临床PGT病例(共27378枚胚胎),0.45%(29例)被定义为近亲血缘关系病例。
要点
- 以≥2枚胚胎的纯合区域百分比≥0.5%为阈值定义近亲血缘关系病例。
- 验证集中5例阳性对照均符合该标准,24例阴性对照均不符合。
- 6380例临床PGT病例中0.45%(29例)被定义为近亲血缘关系。
核心结论
- 基于单核苷酸多态性微阵列的PGT平台可在常规遗传学检测中通过评估体外受精来源胚胎的纯合区域来常规筛查父母近亲血缘关系,无需事先知晓父母关系。
研究设计与样本
- 验证集为29例临床PGT病例,包括5例确诊近亲血缘关系的阳性对照病例和24例随机选取的非近亲血缘关系阴性对照病例。
- 使用PLINK软件识别每条常染色体上大于5 Mb的所有纯合区域,计算纯合区域百分比并在阳性与阴性对照病例间比较以确定阈值。
- 将该阈值应用于单一PGT实验室的6380例临床PGT病例(共27378枚胚胎)以计算近亲血缘关系病例的患病率。
主要发现
- 所选定标准将含有两枚或以上纯合区域百分比≥0.5%胚胎的病例定义为近亲血缘关系。
- 验证集中阳性对照病例符合该标准,阴性对照病例不符合该标准。
- 在评估的6380例病例中,0.45%(29例)被定义为近亲血缘关系。
关键数值与推荐
- 近亲血缘关系判定标准:病例含有两枚或以上纯合区域百分比≥0.5%的胚胎。
- 纯合区域识别阈值:每条常染色体上大于5 Mb的纯合区域。
临床怎么用
- 该PGT平台可在常规遗传学检测中通过评估体外受精来源胚胎的纯合区域来常规筛查父母近亲血缘关系,无需事先知晓父母关系。
- 作者认为这有助于提高PGT的效用并识别与近亲血缘关系相关的隐性遗传病风险增加的胚胎。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Can a single-nucleotide polymorphism array-based preimplantation genetic testing (PGT) platform routinely detect consanguinity in preimplantation embryos? DESIGN: A validation set consisting of 29 clinical PGT cases (five cases with confirmed consanguinity [positive control cases] and 24 randomly selected non-consanguineous cases [negative control cases]) was used to define a genetic threshold for the routine detection of consanguinity. PLINK software was used to identify all regions of homozygosity (ROH) greater than 5 Mb on each autosome. The percentage of ROH was then calculated and compared between the positive and negative control cases to determine a threshold. Next, the threshold was used to create a specific criterion that was applied to 6,380 clinical PGT cases (27,378 embryos in total) to calculate the prevalence of consanguineous cases within a single PGT laboratory. RESULTS: The selected criterion defined cases as consanguineous when they contained two or more embryos with ROH percentages of 0.5% or more. Positive and negative control cases from the validation set fulfilled and failed this criterion, respectively. Of the 6380 cases evaluated, 0.45% (29) were defined as consanguineous. CONCLUSIONS: This study describes a PGT platform that can routinely screen for parental consanguinity by evaluating regions of homozygosity in IVF-derived embryos during routine genetic testing. Consanguinity can be detected without prior knowledge of a parental relationship. This can help to improve the utility of PGT and identify embryos at increased risk of recessive disease associated with consanguinity.
引用
- Kratka C, Xu J, Eccles J, et al. Routine detection of consanguinity through preimplantation genetic testing in human embryos. Reprod Biomed Online. 2024. PMID: 40024009. doi:10.1016/j.rbmo.2024.104453
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。